← FDA DRUG APPROVALS

FDA ANDA · ANDA202310

MORPHINE SULFATE

Sponsor: CHARTWELL MOLECULAR

APPLICATION
ANDA202310
TYPE
ANDA
ORIGINAL APPROVAL
2015-10-30
LATEST ACTION
2020-02-10
ROUTE
ORAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued

Products

MORPHINE SULFATEDiscontinued
MORPHINE SULFATE 20MG/5ML · SOLUTION · ORAL

Approval history

2020-02-10Labeling · Supplement 3 · standardAP
2020-02-10Labeling · Supplement 1 · standardAP
2018-09-18REMS · Supplement 2 · standardAP
2015-10-30OriginalREMSAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →